211At-PSMA5

N/A

Report date: 2025/11/21 17:15:22

NME

Base Information

Drug Name211At-PSMA5

Drug Alias Nameαf-002

ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Astatine > 211At +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesAlpha Fusion Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlpha Fusion Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A